Bringing New Technologies to Market: Hurdles and Solutions
To access this article, please choose from the options below
Conflicts of Interest The author has made the following disclosures: Board of Directors: EndoChoice, Inc, Early Bird Alert, Inc; Executive Management Board and Chief Medical Officer: AGA Digestive Health Outcomes Registry. Advisor (in the past 24 months): Auxilium Pharmaceuticals, Centocor Ortho Biotech LLC, Eisai Pharmaceuticals, Novartis Corporation, SciDose LLC, The SmartPill Company, Boston Scientific, Given Imaging Ltd, Avantis Medical System Inc, Resonance Health Ltd, Xlumina, Vysera Biomedical Limited, Mauna Kea Technologies, EndoGastric Solutions, Exalenz Bioscience Ltd, Sandhill Scientific, Ethicon Endo-Surgery. Personal Possession of Shares: Early Bird Alert, Inc, Given Imaging Ltd. Options: EndoChoice, Inc, Early Bird Alert, Inc.
PII: S0016-5085(10)00731-6
doi:10.1053/j.gastro.2010.05.003
© 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.

